Castleview Partners’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Castleview Partners’s Portfolio AWH Stock Details AWH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,316	Closed	-$1.96K	–	957
2024 Q2	$1.96K	Hold	1,316	–	–	﹤0.01%	742
2024 Q1	$4.08K	Hold	1,316	–	–	﹤0.01%	664
2023 Q4	$5.37K	Hold	1,316	–	–	﹤0.01%	575
2023 Q3	$7.05K	Hold	1,316	–	–	0.01%	448
2023 Q2	$4.36K	Buy	+1,316	New	+$5.54K	﹤0.01%	525
2023 Q1	–	Sell	-1,317	Closed	-$6.57K	–	722
2022 Q4	$6.57K	Hold	1,317	–	–	0.01%	420
2022 Q3	$7K	Buy	+1,317	New	+$14.2K	0.01%	427

Other funds holding AWH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

QPW

Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Castleview Partners's AWH Position: Q3 2024 in Review

Castleview Partners sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q3 2024, closing a stake of 1,316 shares — an estimated $1.96K sold.

Castleview Partners first reported a position in AWH in Q3 2022 and held it in 7 quarters. The position peaked at $7.05K in Q3 2023. 25 funds tracked by Wall St. Rank hold AWH as of Q3 2024.

Castleview Partners reported no remaining Aspira Women's Health Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Castleview Partners sold 1,316 Aspira Women's Health Inc. Common Stock shares in Q3 2024, an estimated $1.96K.
Castleview Partners first reported a position in Aspira Women's Health Inc. Common Stock in Q3 2022 and held it in 7 quarters.
Castleview Partners's Aspira Women's Health Inc. Common Stock position peaked at $7.05K in Q3 2023.
25 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.